Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.

Veenhoven R, Bogaert D, Uiterwaal C, Brouwer C, Kiezebrink H, Bruin J, IJzerman E, Hermans P, de Groot R, Zegers B, Kuis W, Rijkers G, Schilder A, Sanders E.

Lancet. 2003 Jun 28;361(9376):2189-95.

PMID:
12842372
2.

Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?

van Kempen MJ, Vermeiren JS, Vaneechoutte M, Claeys G, Veenhoven RH, Rijkers GT, Sanders EA, Dhooge IJ.

Int J Pediatr Otorhinolaryngol. 2006 Feb;70(2):275-85. Epub 2005 Sep 2.

PMID:
16140397
3.

Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.

Veenhoven RH, Bogaert D, Schilder AG, Rijkers GT, Uiterwaal CS, Kiezebrink HH, van Kempen MJ, Dhooge IJ, Bruin J, Ijzerman EP, de Groot R, Kuis W, Hermans PW, Sanders EA.

Clin Infect Dis. 2004 Oct 1;39(7):911-9. Epub 2004 Sep 1.

PMID:
15472839
4.

Pneumococcal vaccines for preventing otitis media.

Straetemans M, Sanders EA, Veenhoven RH, Schilder AG, Damoiseaux RA, Zielhuis GA.

Cochrane Database Syst Rev. 2004;(1):CD001480. Review. Update in: Cochrane Database Syst Rev. 2009;(2):CD001480.

PMID:
14973970
5.

Pneumococcal conjugate vaccines for preventing otitis media.

Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, Damoiseaux RA.

Cochrane Database Syst Rev. 2014 Apr 2;(4):CD001480. doi: 10.1002/14651858.CD001480.pub4. Review.

PMID:
24696098
6.

Efficacy of a pneumococcal conjugate vaccine against acute otitis media.

Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Käyhty H, Karma P, Kohberger R, Siber G, Mäkelä PH; Finnish Otitis Media Study Group..

N Engl J Med. 2001 Feb 8;344(6):403-9.

7.

Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.

Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L.

Lancet. 2006 Mar 4;367(9512):740-8.

PMID:
16517274
8.

Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.

Kilpi T, Ahman H, Jokinen J, Lankinen KS, Palmu A, Savolainen H, Grönholm M, Leinonen M, Hovi T, Eskola J, Käyhty H, Bohidar N, Sadoff JC, Mäkelä PH; Finnish Otitis Media Study Group..

Clin Infect Dis. 2003 Nov 1;37(9):1155-64. Epub 2003 Oct 7.

PMID:
14557958
9.

Use of pneumococcal vaccine for prevention of recurrent acute otitis media in infants in Boston. The Greater Boston Collaborative Otitis Media Study Group.

Teele DW, Klein JO, Bratton L, Fisch GR, Mathieu OR, Porter PJ, Starobin SG, Tarlin LD, Younes RP.

Rev Infect Dis. 1981 Mar-Apr;3 Suppl:S113-8.

PMID:
7280443
10.

New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.

Casey JR, Adlowitz DG, Pichichero ME.

Pediatr Infect Dis J. 2010 Apr;29(4):304-9. doi: 10.1097/INF.0b013e3181c1bc48.

11.

Review of randomized controlled trials on pneumococcal vaccination for prevention of otitis media.

Straetemans M, Sanders EA, Veenhoven RH, Schilder AG, Damoiseaux RA, Zielhuis GA.

Pediatr Infect Dis J. 2003 Jun;22(6):515-24. Review.

PMID:
12799508
12.

Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect.

Palmu AA, Jokinen JT, Kaijalainen T, Leinonen M, Karma P, Kilpi TM.

Clin Infect Dis. 2005 Jan 1;40(1):52-7. Epub 2004 Dec 6.

PMID:
15614692
13.

Pneumococcal conjugate vaccines for preventing otitis media.

Jansen AG, Hak E, Veenhoven RH, Damoiseaux RA, Schilder AG, Sanders EA.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001480. doi: 10.1002/14651858.CD001480.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD001480.

PMID:
19370566
14.

Etiology and antimicrobial susceptibility of middle ear fluid pathogens in Costa Rican children with otitis media before and after the introduction of the 7-valent pneumococcal conjugate vaccine in the National Immunization Program: acute otitis media microbiology in Costa Rican children.

Abdelnour A, Arguedas A, Dagan R, Soley C, Porat N, Castrejon MM, Ortega-Barria E, Colindres R, Pirçon JY, DeAntonio R, Van Dyke MK.

Medicine (Baltimore). 2015 Jan;94(2):e320. doi: 10.1097/MD.0000000000000320.

15.

Pneumococcal vaccines for preventing otitis media.

Straetemans M, Sanders EA, Veenhoven RH, Schilder AG, Damoiseaux RA, Zielhuis GA.

Cochrane Database Syst Rev. 2002;(2):CD001480. Review. Update in: Cochrane Database Syst Rev. 2004;(1):CD001480.

PMID:
12076412
16.

Pneumococcal acute otitis media in infants and children in central Romania, 2009-2011: microbiological characteristics and potential coverage by pneumococcal conjugate vaccines.

Falup-Pecurariu O, Leibovitz E, Mercas A, Bleotu L, Zavarache C, Porat N, Dagan R, Greenberg D.

Int J Infect Dis. 2013 Sep;17(9):e702-6. doi: 10.1016/j.ijid.2013.02.002. Epub 2013 Mar 20.

17.

Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain.

Alonso M, Marimon JM, Ercibengoa M, Pérez-Yarza EG, Pérez-Trallero E.

PLoS One. 2013;8(1):e54333. doi: 10.1371/journal.pone.0054333. Epub 2013 Jan 22.

18.

Probiotics and prebiotics in preventing episodes of acute otitis media in high-risk children: a randomized, double-blind, placebo-controlled study.

Cohen R, Martin E, de La Rocque F, Thollot F, Pecquet S, Werner A, Boucherat M, Varon E, Bingen E, Levy C.

Pediatr Infect Dis J. 2013 Aug;32(8):810-4. doi: 10.1097/INF.0b013e31828df4f3.

PMID:
23429555
19.

Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media.

Revai K, McCormick DP, Patel J, Grady JJ, Saeed K, Chonmaitree T.

Pediatrics. 2006 May;117(5):1823-9.

PMID:
16651345
20.

Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media: a randomized, controlled trial.

Brouwer CN, Maillé AR, Rovers MM, Veenhoven RH, Grobbee DE, Sanders EA, Schilder AG.

Pediatrics. 2005 Feb;115(2):273-9.

PMID:
15687432

Supplemental Content

Support Center